Inventor · disambiguated record
Xing-Xian Yu
Also filed as: YU XING-XIAN
12 granted patents·8 pending applications·183 citations·filing 2001–2014
89Inventor score
Top patents by PatentIndex Score
20 records- 0198US7732590B2Modulation of diacylglycerol acyltransferase 2 expressionISIS PHARMACEUTICALS INC·Filed 2005·Granted Jun 8, 2010·132 cites·31 claims
- 0293US8258289B2Modulation of diacylglycerol acyltransferase 2 expressionBHANOT SANJAY·Filed 2010·Granted Sep 4, 2012·20 cites·24 claims
- 0390US8101585B2Compositions and methods for the modulation of JNK proteinsYU XING-XIAN·Filed 2007·Granted Jan 24, 2012·18 cites·30 claims
- 0483US8541388B2Methods for modulating expression of RBP4MONIA BRETT P·Filed 2009·Granted Sep 24, 2013·6 cites·35 claims
- 0580US8486904B2Antisense modulation of fibroblast growth factor receptor 4 expressionBHANOT SANJAY·Filed 2008·Granted Jul 16, 2013·3 cites·25 claims
- 0672US7141421B2Control of metabolism with human 2-oxoglutarate carrierGENENTECH INC·Filed 2001·Granted Nov 28, 2006·2 cites·10 claims
- 0769US8455456B2Compositions and their uses directed to diacylglycerol acyltransferase 1YU XING-XIAN·Filed 2011·Granted Jun 4, 2013·1 cites·24 claims
- 0865US7825235B2Modulation of diacylglycerol acyltransferase 2 expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Nov 2, 2010·1 cites·40 claims
- 0964US8003620B2Compositions and their uses directed to diacylglycerol acyltransferase 1ISIS PHARMACEUTICALS INC·Filed 2007·Granted Aug 23, 2011·0 cites·33 claims
- 1060US8883997B2Modulation of diacylglycerol acyltransferase 2 expressionBHANOT SANJAY·Filed 2012·Granted Nov 11, 2014·0 cites·20 claims
- 1159US2004146908A1Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disordersGENENTECH INC·Filed 2003·Application pending·0 cites
- 1254US8933213B2Antisense modulation of fibroblast growth factor receptor 4 expressionISIS PHARMACEUTICALS INC·Filed 2012·Granted Jan 13, 2015·0 cites·9 claims
- 1354US2005026832A1Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disordersGENENTECH INC·Filed 2004·Application pending·0 cites
- 1454US2015184164A1Antisense modulation of fibroblast growth factor receptor 4 expressionISIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1553US8895529B2Antisense modulation of fibroblast growth factor receptor 4 expressionISIS PHARMACEUTICALS INC·Filed 2013·Granted Nov 25, 2014·0 cites·25 claims
- 1652US2002155543A1Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disordersGENENTECH INC·Filed 2001·Application pending·0 cites
- 1751US2011177097A1Methods for modulating expression of crebSHULMAN GERALD·Filed 2009·Application pending·0 cites
- 1846US2014275207A1Antisense compounds and methods of use thereofISIS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1945US2012214736A1Compositions and methods for the modulation of jnk proteinsYU XING-XIAN·Filed 2011·Application pending·0 cites
- 2043US2009221671A1Modulation of lmw-ptpase expressionPANDEY SANJAY·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →